[1]
Martha Lilac Ketisha Antoine, M. and Xu, Y. 2020. Sodium-glucose cotransporter-2 inhibitors: current knowledge on the use of canagliflozin, dapagliflozin and empagliflozin in the treatment of type 2 diabetes mellitus. International Journal of Medicine. 8, 1 (Mar. 2020), 8–12. DOI:https://doi.org/10.14419/ijm.v8i1.30308.